Evfm forecast
WebApr 6, 2024 · Evofem Biosciences (EVFM) Looks Good: Stock Adds 10.1% in Session. 06/26/20-7:44AM EST Zacks. More Zacks News for EVFM ». WebSee Evofem Biosciences, Inc. (EVFM) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.
Evfm forecast
Did you know?
WebAverage Return. +98.14%. reiterated a sell rating 6 months ago. Copying Jeffrey Hung 's trades and holding each position for 1 Year would result in +100.00% of your transactions generating a profit, with an average … WebStock Price Forecast. The 1 analysts offering 12-month price forecasts for Evofem Biosciences Inc have a median target of 1.80, with a high estimate of 1.80 and a low estimate of 1.80. The median estimate represents a +7,494.94% increase from the last price of 0.02. Chart unavailable.
WebFORECAST . Local; Graphical; Aviation; Marine; Rivers and Lakes; Hurricanes; Severe Weather; Fire Weather; Sun/Moon; Long Range Forecasts; Climate Prediction; Space … WebMay 18, 2024 · By Robert Lakin, InvestorPlace Contributor May 18, 2024, 9:20 am EDT. Shares of Evofem Biosciences (NASDAQ: EVFM) sunk by more than 36% in pre-market trading on Tuesday after pricing a $50 million ...
WebEvofem Biosciences Inc () Stock Market info Recommendations: Buy or sell Evofem Biosciences stock? Wall Street Stock Market & Finance report, prediction for the future: … WebApr 4, 2024 · View our EVFM earnings forecast. How were Evofem Biosciences' earnings last quarter? Evofem Biosciences, Inc. (NASDAQ:EVFM) announced its earnings results on Monday, November, 15th. The biotechnology company reported ($7.20) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($4.50) by $2.70. The …
WebApr 10, 2024 · Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women’s sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, an …
WebEvofem Biosciences Inc's (NASDAQ: EVFM) Q2 Phexxi sales increased 42% Y/Y to $6.0 million, reflecting higher ex-factory sales and lower gross-to-net adjustments of 40%. The company's operating ... maybelline flawless foundationWeb19 hours ago · evfm 0.02 0.00(-2.01%) Will EVFM be a Portfolio Killer in April? Zacks Investment Research is releasing its prediction for EVFM based on the 1-3 month trading system that more than doubles the S&P ... maybelline fit sand concealerWeb2 days ago · SAN DIEGO, April 12, 2024 /PRNewswire/ -- Evofem Biosciences, Inc., (OTCQB: EVFM) today announced a major new win in New York state that improves coverage for Phexxi® (lactic acid, citric acid ... hershey centre arenaWebApr 6, 2024 · View Evofem Biosciences, Inc EVFM investment & stock information. Get the latest Evofem Biosciences, Inc EVFM detailed stock quotes, stock data, Real-Time … hershey center paWebApr 13, 2024 · EVFM Stock Forecast: Q2 Results. Revenue for the company stood at $6.03M with a YoY growth rate at 224.9%. It is an improvement from the last quarter … maybelline florida websiteWebAbout the Evofem Biosciences, Inc. stock forecast. As of 2024 April 10, Monday current price of EVFM stock is 0.0190$ and our data indicates that the asset price has been in a … hershey centre gymnasticsWebApr 9, 2024 · 4 brokerages have issued twelve-month target prices for Evofem Biosciences' stock. Their EVFM share price forecasts range from $3.50 to $8.55. On average, they … According to the issued ratings of 3 analysts in the last year, the consensus rating for … maybelline foundation 24h